217 related articles for article (PubMed ID: 30785734)
1. Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.
Denisov IG; Grinkova YV; Nandigrami P; Shekhar M; Tajkhorshid E; Sligar SG
Biochemistry; 2019 Mar; 58(10):1411-1422. PubMed ID: 30785734
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.
Denisov IG; Grinkova YV; Baylon JL; Tajkhorshid E; Sligar SG
Biochemistry; 2015 Apr; 54(13):2227-39. PubMed ID: 25777547
[TBL] [Abstract][Full Text] [Related]
3. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
[TBL] [Abstract][Full Text] [Related]
4. Midazolam as a Probe for Drug-Drug Interactions Mediated by CYP3A4: Homotropic Allosteric Mechanism of Site-Specific Hydroxylation.
Denisov IG; Grinkova YV; Camp T; McLean MA; Sligar SG
Biochemistry; 2021 Jun; 60(21):1670-1681. PubMed ID: 34015213
[TBL] [Abstract][Full Text] [Related]
5. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
[TBL] [Abstract][Full Text] [Related]
6. Allosteric Activation of Cytochrome P450 3A4 via Progesterone Bioconjugation.
Polic V; Auclair K
Bioconjug Chem; 2017 Apr; 28(4):885-889. PubMed ID: 28339191
[TBL] [Abstract][Full Text] [Related]
7. CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
Kang P; Liao M; Wester MR; Leeder JS; Pearce RE; Correia MA
Drug Metab Dispos; 2008 Mar; 36(3):490-9. PubMed ID: 18096676
[TBL] [Abstract][Full Text] [Related]
8. Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.
Denisov IG; Grinkova YV; McLean MA; Camp T; Sligar SG
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740978
[TBL] [Abstract][Full Text] [Related]
9. Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4.
Torimoto N; Ishii I; Hata M; Nakamura H; Imada H; Ariyoshi N; Ohmori S; Igarashi T; Kitada M
Biochemistry; 2003 Dec; 42(51):15068-77. PubMed ID: 14690416
[TBL] [Abstract][Full Text] [Related]
10. Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4.
Rougée LRA; Bedwell DW; Hansen K; Abraham TL; Hall SD
Drug Metab Dispos; 2023 Oct; 51(10):1372-1380. PubMed ID: 37524542
[TBL] [Abstract][Full Text] [Related]
11. A Covalently Attached Progesterone Molecule Outcompetes the Binding of Free Progesterone at an Allosteric Site of Cytochrome P450 3A4.
Ducharme J; Polic V; Auclair K
Bioconjug Chem; 2019 Jun; 30(6):1629-1635. PubMed ID: 31083930
[TBL] [Abstract][Full Text] [Related]
12. Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity.
Domanski TL; He YA; Khan KK; Roussel F; Wang Q; Halpert JR
Biochemistry; 2001 Aug; 40(34):10150-60. PubMed ID: 11513592
[TBL] [Abstract][Full Text] [Related]
13. Cooperativity in cytochrome P450 3A4: linkages in substrate binding, spin state, uncoupling, and product formation.
Denisov IG; Baas BJ; Grinkova YV; Sligar SG
J Biol Chem; 2007 Mar; 282(10):7066-76. PubMed ID: 17213193
[TBL] [Abstract][Full Text] [Related]
14. An epoxidation mechanism of carbamazepine by CYP3A4.
Hata M; Tanaka Y; Kyoda N; Osakabe T; Yuki H; Ishii I; Kitada M; Neya S; Hoshino T
Bioorg Med Chem; 2008 May; 16(9):5134-48. PubMed ID: 18372180
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
Inui H; Maeda A; Ohkawa H
Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
[TBL] [Abstract][Full Text] [Related]
16. Drug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4.
Denisov IG; Baylon JL; Grinkova YV; Tajkhorshid E; Sligar SG
Biochemistry; 2018 Feb; 57(5):805-816. PubMed ID: 29200287
[TBL] [Abstract][Full Text] [Related]
17. Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency.
Polic V; Sevrioukova IF; Auclair K
Arch Biochem Biophys; 2018 Sep; 653():90-96. PubMed ID: 29958895
[TBL] [Abstract][Full Text] [Related]
18. Dynamics and Location of the Allosteric Midazolam Site in Cytochrome P4503A4 in Lipid Nanodiscs.
Redhair M; Hackett JC; Pelletier RD; Atkins WM
Biochemistry; 2020 Feb; 59(6):766-779. PubMed ID: 31961139
[TBL] [Abstract][Full Text] [Related]
19. Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.
Yuki H; Honma T; Hata M; Hoshino T
Bioorg Med Chem; 2012 Jan; 20(2):775-83. PubMed ID: 22197672
[TBL] [Abstract][Full Text] [Related]
20. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation.
Kerr BM; Thummel KE; Wurden CJ; Klein SM; Kroetz DL; Gonzalez FJ; Levy RH
Biochem Pharmacol; 1994 Jun; 47(11):1969-79. PubMed ID: 8010982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
